Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Mediplast A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.9% 1.0% 0.6% 1.4% 0.6% 0.6% 5.8% 5.7%   Credit score (0-100)   90 87 97 77 96 97 14 14   Credit rating   A A A BBB A A BB BB   Credit limit (kDKK)   1,669.8 1,275.8 2,733.5 92.7 2,130.3 2,317.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   16,408 18,076 23,634 11,109 19,714 20,485 0.0 0.0   EBITDA   4,102 6,629 12,026 2,068 9,513 10,342 0.0 0.0   EBIT   4,036 6,503 11,863 1,913 9,381 10,220 0.0 0.0   Pre-tax profit (PTP)   3,995.1 6,535.2 11,863.5 1,877.9 9,451.4 10,561.1 0.0 0.0   Net earnings   3,119.0 5,065.6 9,271.1 1,457.4 7,367.4 8,240.8 0.0 0.0   Pre-tax profit without non-rec. items   3,995 6,535 11,864 1,878 9,451 10,561 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   105 252 190 126 64.3 13.0 0.0 0.0   Shareholders equity total   17,118 14,183 18,454 6,912 14,279 15,520 6,020 6,020   Interest-bearing liabilities   17,568 17,587 66.4 9,230 8,458 20,204 0.0 0.0   Balance sheet total (assets)   40,894 37,455 30,028 21,892 25,509 38,327 6,020 6,020   Net Debt   13,064 14,708 0.7 9,230 8,458 20,204 -5,856 -5,856     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   16,408 18,076 23,634 11,109 19,714 20,485 0.0 0.0   Gross profit growth   -1.4% 10.2% 30.7% -53.0% 77.5% 3.9% -100.0% 0.0%   Employees   0 16 0 12 13 13 0 0   Employee growth %   0.0% 0.0% -100.0% 0.0% 8.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   40,894 37,455 30,028 21,892 25,509 38,327 6,020 6,020   Balance sheet change%   -28.6% -8.4% -19.8% -27.1% 16.5% 50.3% -84.3% 0.0%   Added value   4,102.1 6,629.1 12,025.9 2,067.7 9,536.0 10,341.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -78 467 -295 -290 -264 -243 -13 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.6% 36.0% 50.2% 17.2% 47.6% 49.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.8% 17.2% 35.7% 7.5% 39.9% 33.4% 0.0% 0.0%   ROI %   9.9% 20.2% 47.9% 11.2% 48.7% 36.4% 0.0% 0.0%   ROE %   18.3% 32.4% 56.8% 11.5% 69.5% 55.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   41.9% 37.9% 61.5% 31.6% 56.0% 40.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   318.5% 221.9% 0.0% 446.4% 88.9% 195.4% 0.0% 0.0%   Gearing %   102.6% 124.0% 0.4% 133.5% 59.2% 130.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.2% 1.1% 2.1% 1.3% 0.1% 0.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   5.9 6.1 1.8 1.2 2.0 1.5 0.0 0.0   Current Ratio   6.3 6.3 2.5 1.4 2.2 1.7 0.0 0.0   Cash and cash equivalent   4,503.6 2,878.9 65.7 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   33,099.3 30,745.3 17,648.3 6,234.3 13,727.6 15,061.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 414 0 172 734 796 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 414 0 172 732 796 0 0   EBIT / employee   0 406 0 159 722 786 0 0   Net earnings / employee   0 317 0 121 567 634 0 0